Report Detail
Global Bipolar Disorder Therapeutic Market Research Report 2019
- RnM3123161 |
- 14 March, 2019 |
- Global |
- 96 Pages |
- QYResearch |
- Pharma & Healthcare
Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. According to Pfizer, Inc., bipolar disorder affects over 5 million people in the U.S. Bipolar episodes are characterized by a drastic change in behavior and mood, and range from joyful and overexcited (manic episodes) to extremely sad and hopeless (depressive state). These disorders have different types of episodes such as manic episodes, hypomanic episodes, depressive episodes, and mixed episodes. Causes of bipolar disorders include childhood trauma, stressful life events, self-esteem problems, and genetic inheritance. People across the world marked “March 30” as a World Bipolar Day to spread awareness about the disorder and erase the stigma of mental illness. Large number of people suffering from this mental condition resort to drinking to lift their mood. According to the National Institute on Alcohol Abuse and Alcoholism, 27.6% of the people with bipolar disorder become addicted to alcohol, while over 16% engaged in alcohol abuse.
The growing need to reduce the financial burden of bipolar disorder will drive the growth prospects for the global bipolar disorder therapeutic market until the end of 2021. It has been observed that governments and companies across the globe are increasingly organizing awareness camps to raise disease awareness among the public, reduce the burden of mental disorders in vulnerable groups, ensure the rights of people with mental disorders, and make treatment facilities accessible to them. Consequently, such awareness initiatives help to curb the overall monetary loss, reduce their effect on the global economy, and improve the quality of life for patients. Such factors will raise public awareness about mental disorders and treatments and in turn, propel the rate of revenue generation in the market.
The Americas accounted for the majority market share during 2016 and will continue to dominate the market during the forecasted period. Some of the major factors responsible for the market's growth in the region are the high incidence of bipolar disorder symptoms in the US, the growing number of pipeline products, the rising awareness about these disorders in the region, and the growing prevalence of pediatric bipolar disorders.
The global Bipolar Disorder Therapeutic market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Bipolar Disorder Therapeutic volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bipolar Disorder Therapeutic market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Allergan
Astellas Pharma
GlaxoSmithKline
Janssen Pharmaceuticals
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Antipsychotics
Anticonvulsants
Mood Stabilizers
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Table of Contents
Executive Summary
1 Bipolar Disorder Therapeutic Market Overview
- 1.1 Product Overview and Scope of Bipolar Disorder Therapeutic
- 1.2 Bipolar Disorder Therapeutic Segment by Type
- 1.2.1 Global Bipolar Disorder Therapeutic Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Antipsychotics
- 1.2.3 Anticonvulsants
- 1.2.4 Mood Stabilizers
- 1.3 Bipolar Disorder Therapeutic Segment by Application
- 1.3.1 Bipolar Disorder Therapeutic Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospital Pharmacies
- 1.3.3 Retail Pharmacies
- 1.3.4 Online Pharmacies
- 1.4 Global Bipolar Disorder Therapeutic Market by Region
- 1.4.1 Global Bipolar Disorder Therapeutic Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Bipolar Disorder Therapeutic Market Size
- 1.5.1 Global Bipolar Disorder Therapeutic Revenue (2014-2025)
- 1.5.2 Global Bipolar Disorder Therapeutic Production (2014-2025)
2 Global Bipolar Disorder Therapeutic Market Competition by Manufacturers
- 2.1 Global Bipolar Disorder Therapeutic Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Bipolar Disorder Therapeutic Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Bipolar Disorder Therapeutic Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Bipolar Disorder Therapeutic Production Sites, Area Served, Product Types
- 2.5 Bipolar Disorder Therapeutic Market Competitive Situation and Trends
- 2.5.1 Bipolar Disorder Therapeutic Market Concentration Rate
- 2.5.2 Bipolar Disorder Therapeutic Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Bipolar Disorder Therapeutic Production Market Share by Regions
- 3.1 Global Bipolar Disorder Therapeutic Production Market Share by Regions
- 3.2 Global Bipolar Disorder Therapeutic Revenue Market Share by Regions (2014-2019)
- 3.3 Global Bipolar Disorder Therapeutic Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Bipolar Disorder Therapeutic Production
- 3.4.1 North America Bipolar Disorder Therapeutic Production Growth Rate (2014-2019)
- 3.4.2 North America Bipolar Disorder Therapeutic Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Bipolar Disorder Therapeutic Production
- 3.5.1 Europe Bipolar Disorder Therapeutic Production Growth Rate (2014-2019)
- 3.5.2 Europe Bipolar Disorder Therapeutic Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Bipolar Disorder Therapeutic Production (2014-2019)
- 3.6.1 China Bipolar Disorder Therapeutic Production Growth Rate (2014-2019)
- 3.6.2 China Bipolar Disorder Therapeutic Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Bipolar Disorder Therapeutic Production (2014-2019)
- 3.7.1 Japan Bipolar Disorder Therapeutic Production Growth Rate (2014-2019)
- 3.7.2 Japan Bipolar Disorder Therapeutic Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Bipolar Disorder Therapeutic Consumption by Regions
- 4.1 Global Bipolar Disorder Therapeutic Consumption by Regions
- 4.2 North America Bipolar Disorder Therapeutic Consumption (2014-2019)
- 4.3 Europe Bipolar Disorder Therapeutic Consumption (2014-2019)
- 4.4 China Bipolar Disorder Therapeutic Consumption (2014-2019)
- 4.5 Japan Bipolar Disorder Therapeutic Consumption (2014-2019)
5 Global Bipolar Disorder Therapeutic Production, Revenue, Price Trend by Type
- 5.1 Global Bipolar Disorder Therapeutic Production Market Share by Type (2014-2019)
- 5.2 Global Bipolar Disorder Therapeutic Revenue Market Share by Type (2014-2019)
- 5.3 Global Bipolar Disorder Therapeutic Price by Type (2014-2019)
- 5.4 Global Bipolar Disorder Therapeutic Production Growth by Type (2014-2019)
6 Global Bipolar Disorder Therapeutic Market Analysis by Applications
- 6.1 Global Bipolar Disorder Therapeutic Consumption Market Share by Application (2014-2019)
- 6.2 Global Bipolar Disorder Therapeutic Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Bipolar Disorder Therapeutic Business
- 7.1 Eli Lilly
- 7.1.1 Eli Lilly Bipolar Disorder Therapeutic Production Sites and Area Served
- 7.1.2 Bipolar Disorder Therapeutic Product Introduction, Application and Specification
- 7.1.3 Eli Lilly Bipolar Disorder Therapeutic Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Bristol-Myers Squibb
- 7.2.1 Bristol-Myers Squibb Bipolar Disorder Therapeutic Production Sites and Area Served
- 7.2.2 Bipolar Disorder Therapeutic Product Introduction, Application and Specification
- 7.2.3 Bristol-Myers Squibb Bipolar Disorder Therapeutic Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 AstraZeneca
- 7.3.1 AstraZeneca Bipolar Disorder Therapeutic Production Sites and Area Served
- 7.3.2 Bipolar Disorder Therapeutic Product Introduction, Application and Specification
- 7.3.3 AstraZeneca Bipolar Disorder Therapeutic Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Allergan
- 7.4.1 Allergan Bipolar Disorder Therapeutic Production Sites and Area Served
- 7.4.2 Bipolar Disorder Therapeutic Product Introduction, Application and Specification
- 7.4.3 Allergan Bipolar Disorder Therapeutic Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Astellas Pharma
- 7.5.1 Astellas Pharma Bipolar Disorder Therapeutic Production Sites and Area Served
- 7.5.2 Bipolar Disorder Therapeutic Product Introduction, Application and Specification
- 7.5.3 Astellas Pharma Bipolar Disorder Therapeutic Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 GlaxoSmithKline
- 7.6.1 GlaxoSmithKline Bipolar Disorder Therapeutic Production Sites and Area Served
- 7.6.2 Bipolar Disorder Therapeutic Product Introduction, Application and Specification
- 7.6.3 GlaxoSmithKline Bipolar Disorder Therapeutic Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Janssen Pharmaceuticals
- 7.7.1 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Production Sites and Area Served
- 7.7.2 Bipolar Disorder Therapeutic Product Introduction, Application and Specification
- 7.7.3 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
8 Bipolar Disorder Therapeutic Manufacturing Cost Analysis
- 8.1 Bipolar Disorder Therapeutic Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Bipolar Disorder Therapeutic
- 8.4 Bipolar Disorder Therapeutic Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Bipolar Disorder Therapeutic Distributors List
- 9.3 Bipolar Disorder Therapeutic Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Bipolar Disorder Therapeutic Market Forecast
- 11.1 Global Bipolar Disorder Therapeutic Production, Revenue Forecast
- 11.1.1 Global Bipolar Disorder Therapeutic Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Bipolar Disorder Therapeutic Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Bipolar Disorder Therapeutic Price and Trend Forecast (2019-2025)
- 11.2 Global Bipolar Disorder Therapeutic Production Forecast by Regions (2019-2025)
- 11.2.1 North America Bipolar Disorder Therapeutic Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Bipolar Disorder Therapeutic Production, Revenue Forecast (2019-2025)
- 11.2.3 China Bipolar Disorder Therapeutic Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Bipolar Disorder Therapeutic Production, Revenue Forecast (2019-2025)
- 11.3 Global Bipolar Disorder Therapeutic Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Bipolar Disorder Therapeutic Consumption Forecast (2019-2025)
- 11.3.2 Europe Bipolar Disorder Therapeutic Consumption Forecast (2019-2025)
- 11.3.3 China Bipolar Disorder Therapeutic Consumption Forecast (2019-2025)
- 11.3.4 Japan Bipolar Disorder Therapeutic Consumption Forecast (2019-2025)
- 11.4 Global Bipolar Disorder Therapeutic Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Bipolar Disorder Therapeutic Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Bipolar Disorder Therapeutic . Industry analysis & Market Report on Bipolar Disorder Therapeutic is a syndicated market report, published as Global Bipolar Disorder Therapeutic Market Research Report 2019. It is complete Research Study and Industry Analysis of Bipolar Disorder Therapeutic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
